CareDx Comments on Issuance of Proposed LCD for Molecular Testing for Solid Allograft RejectionBusiness Wire • 08/11/23
CareDx Announces District Court Judge Bars Natera from Falsely Advertising and Overstating the Scientific Performance of its Prospera Transplant TestBusiness Wire • 08/07/23
CareDx's HeartCare Multimodality Service Receives Medicare Coverage for Heart Transplant SurveillanceBusiness Wire • 08/02/23
CareDx Acquires MediGO, an Organ Transplant Supply Chain and Logistics CompanyBusiness Wire • 07/25/23
CareDx Applauds District Court Decision to Uphold Jury Verdict that Natera Falsely Advertised its Prospera Transplant TestBusiness Wire • 07/18/23
CareDx's AlloSure Lung dd-cfDNA Testing Service Receives Medicare Coverage for Lung Transplant Rejection MonitoringBusiness Wire • 07/11/23
5 of Cathie Wood's Sizzling ARK Investment Stocks Are Buy Rated and Trading Under $1024/7 Wall Street • 06/17/23
CareDx Showcases Digital Health Portfolio at 31st Annual UNOS Transplant Management ForumBusiness Wire • 05/16/23
CareDx Showcases Latest Advances Across AlloSeq Lab Products Portfolio at the 36th European Immunogenetics and Histocompatibility ConferenceBusiness Wire • 04/25/23
CareDx Showcases Leadership with Over 55 Oral Presentations and Posters at the 43rd Annual Meeting & Scientific Sessions of the International Society for Heart and Lung TransplantationBusiness Wire • 04/19/23
National Kidney Foundation Honors CareDx with Corporate Citizenship Award for its Commitment to the Transplant CommunityBusiness Wire • 04/06/23
CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human TransplantationBusiness Wire • 04/05/23
CareDx Presents Latest Advancements at 12th Congress of the International Pediatric Transplant AssociationBusiness Wire • 03/23/23